Enzymatica Appoints Holger Lembrér as CFO, Focuses on Global Growth
Photo by servet photograph on Unsplash
Enzymatica has appointed Holger Lembrér as its new CFO, starting no later than April 2026. Mr. Lembrér, formerly CFO at Boule Diagnostics, will join the executive management team and focus on global commercialization and profitable growth, according to the chairman of the board.
Stay updated on stories like this
Key takeaways
- Enzymatica has appointed Holger Lembrér as its new Chief Financial Officer, according to Investing
- Lembrér, whose start date is set for no later than April 2026, will also join the company's executive management team
- He brings extensive experience as a finance executive and CFO for international, publicly listed companies, most recently serving as CFO at Boule Diagnostics
Related Topics
Never miss stories like this
Verified mention available
Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.